60 Degrees Pharmaceuticals, Inc. (SXTP)
0.8701
-0.01
(-0.66%)
USD |
NASDAQ |
Oct 23, 16:00
0.8758
+0.01
(+0.66%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Enterprise Value : 10.92M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 10.92M |
| October 22, 2026 | 10.94M |
| October 21, 2026 | 10.98M |
| October 20, 2026 | 11.06M |
| October 19, 2026 | 10.81M |
| October 16, 2026 | 10.88M |
| October 15, 2026 | 11.00M |
| October 14, 2026 | 10.95M |
| October 13, 2026 | 11.00M |
| October 12, 2026 | 11.05M |
| October 09, 2026 | 11.18M |
| October 08, 2026 | 11.20M |
| October 07, 2026 | 11.54M |
| October 06, 2026 | 11.56M |
| October 05, 2026 | 12.44M |
| October 02, 2026 | 12.31M |
| October 01, 2026 | 11.93M |
| September 30, 2026 | 12.15M |
| September 29, 2026 | 11.93M |
| September 28, 2026 | 11.93M |
| September 25, 2026 | 11.72M |
| September 24, 2026 | 11.67M |
| September 23, 2026 | 11.70M |
| September 22, 2026 | 11.38M |
| September 21, 2026 | 11.30M |
| Date | Value |
|---|---|
| September 18, 2026 | 11.15M |
| September 17, 2026 | 11.25M |
| September 16, 2026 | 11.07M |
| September 15, 2026 | 10.86M |
| September 14, 2026 | 11.00M |
| September 11, 2026 | 11.00M |
| September 10, 2026 | 11.08M |
| September 09, 2026 | 11.11M |
| September 08, 2026 | 11.21M |
| September 04, 2026 | 11.05M |
| September 03, 2026 | 11.08M |
| September 02, 2026 | 11.14M |
| September 01, 2026 | 11.32M |
| August 31, 2026 | 11.48M |
| August 28, 2026 | 11.35M |
| August 27, 2026 | 11.43M |
| August 26, 2026 | 11.48M |
| August 25, 2026 | 11.62M |
| August 24, 2026 | 11.48M |
| August 21, 2026 | 11.62M |
| August 20, 2026 | 11.62M |
| August 19, 2026 | 11.62M |
| August 18, 2026 | 11.59M |
| August 17, 2026 | 11.48M |
| August 14, 2026 | 11.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Harrow, Inc. | 1.283B |
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
| Johnson & Johnson | 662.44B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.263M |
| Revenue (Quarterly) | 0.2079M |
| Total Expenses (Quarterly) | 2.470M |
| EPS Diluted (Quarterly) | -0.903 |
| Gross Profit Margin (Quarterly) | 27.32% |
| Profit Margin (Quarterly) | -1.09K% |
| Earnings Yield | -711.4% |
| Normalized Earnings Yield | -738.39 |